Stock page
BriaPro Therapeutics Corp (DUMY0000077)
BriaPro Therapeutics Corp is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. Its therapies include protein kinase C delta, which has been associated with several diseases including cancer. Selective inhibitors of PKC have been shown to be effective treatments for several animal models of cancer and other diseases. The company's Bria-TILsRx was Developed as potential immunotherapies for cancer. It is a multi-specific binding reagent designed to act as a potent immune cell activator and/or immune checkpoint inhibitor.
Quote snapshot
$0.00
Daily change: —
ExchangeNAS
Updated2026-05-09T04:26:18.403206Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|